Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration
Background Immunotherapies, such as immune checkpoint inhibitors and adoptive cell therapies, have revolutionized cancer treatment and resulted in complete and durable responses in some patients. Unfortunately, most immunotherapy treated patients still fail to respond. Absence of T cell infiltration...
Main Authors: | Juan Wu, Hussein Sultan, Esteban Celis, Andres M Salazar, Valentyna I Fesenkova, Aaron E Fan, Diane Addis |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-09-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/8/2/e001224.full |
Similar Items
-
Correction: Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration
Published: (2024-04-01) -
A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy
by: Jorrit De Waele, et al.
Published: (2021-06-01) -
Tumor-infiltrating lymphocytes for melanoma immunotherapy
by: Oliver Kepp, et al.
Published: (2023-12-01) -
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
by: Yifan Xie, et al.
Published: (2021-11-01) -
Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C
by: Ping Zhu, et al.
Published: (2023-06-01)